skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid

Abstract

(1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 or its pharmaceutically acceptable salts can be used to treat addiction and neurological disorders such as epilepsy without side effects such as visual field defects caused by vigabatrin (Sabril).

Inventors:
; ;
Issue Date:
Research Org.:
Brookhaven National Lab. (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1171656
Patent Number(s):
8969413
Application Number:
13/581,187
Assignee:
Catalyst Pharmaceutical Partners (Coral Gables, FL)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
DOE Contract Number:  
AC02-98CH10886
Resource Type:
Patent
Resource Relation:
Patent File Date: 2011 Feb 25
Country of Publication:
United States
Language:
English
Subject:
37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY

Citation Formats

Silverman, Richard B, Dewey, Stephen L, and Miller, Steven. Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid. United States: N. p., 2015. Web.
Silverman, Richard B, Dewey, Stephen L, & Miller, Steven. Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid. United States.
Silverman, Richard B, Dewey, Stephen L, and Miller, Steven. Tue . "Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid". United States. https://www.osti.gov/servlets/purl/1171656.
@article{osti_1171656,
title = {Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid},
author = {Silverman, Richard B and Dewey, Stephen L and Miller, Steven},
abstractNote = {(1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 or its pharmaceutically acceptable salts can be used to treat addiction and neurological disorders such as epilepsy without side effects such as visual field defects caused by vigabatrin (Sabril).},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2015},
month = {3}
}

Patent:

Save / Share: